vs
Side-by-side financial comparison of HA Sustainable Infrastructure Capital, Inc. (HASI) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.
Nutex Health, Inc. is the larger business by last-quarter revenue ($151.7M vs $114.8M, roughly 1.3× HA Sustainable Infrastructure Capital, Inc.). Nutex Health, Inc. runs the higher net margin — 7.8% vs -46.8%, a 54.6% gap on every dollar of revenue. On growth, HA Sustainable Infrastructure Capital, Inc. posted the faster year-over-year revenue change (13.3% vs -41.1%). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 4.2%).
HA Sustainable Infrastructure Capital, Inc. (HASI) is a specialized investment firm focused on sustainable infrastructure assets covering renewable energy, energy efficiency, sustainable real estate and low-carbon utility segments. It primarily operates in North American markets, providing long-term capital to eligible sustainable projects and delivering stable risk-adjusted returns to investors through recurring cash flows from operational underlying assets.
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
HASI vs NUTX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $114.8M | $151.7M |
| Net Profit | $-53.8M | $11.8M |
| Gross Margin | — | 30.4% |
| Operating Margin | -57.4% | 20.4% |
| Net Margin | -46.8% | 7.8% |
| Revenue YoY | 13.3% | -41.1% |
| Net Profit YoY | -176.7% | -80.8% |
| EPS (diluted) | $-0.38 | $2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $114.8M | $151.7M | ||
| Q3 25 | $103.1M | $267.8M | ||
| Q2 25 | $85.7M | $244.0M | ||
| Q1 25 | $96.9M | $211.8M | ||
| Q4 24 | $101.3M | $257.6M | ||
| Q3 24 | $82.0M | $78.8M | ||
| Q2 24 | $94.5M | $76.1M | ||
| Q1 24 | $105.8M | $67.5M |
| Q4 25 | $-53.8M | $11.8M | ||
| Q3 25 | $83.3M | $55.4M | ||
| Q2 25 | $98.4M | $-17.7M | ||
| Q1 25 | $56.6M | $21.2M | ||
| Q4 24 | $70.1M | $61.6M | ||
| Q3 24 | $-19.6M | $-8.8M | ||
| Q2 24 | $26.5M | $-364.0K | ||
| Q1 24 | $123.0M | $-364.0K |
| Q4 25 | — | 30.4% | ||
| Q3 25 | — | 57.8% | ||
| Q2 25 | — | 51.2% | ||
| Q1 25 | — | 55.9% | ||
| Q4 24 | — | 55.0% | ||
| Q3 24 | — | 27.8% | ||
| Q2 24 | — | 29.7% | ||
| Q1 24 | — | 15.1% |
| Q4 25 | -57.4% | 20.4% | ||
| Q3 25 | — | 48.7% | ||
| Q2 25 | — | 13.8% | ||
| Q1 25 | 84.7% | 38.1% | ||
| Q4 24 | 90.9% | 44.4% | ||
| Q3 24 | -32.1% | 12.3% | ||
| Q2 24 | 39.5% | 7.0% | ||
| Q1 24 | — | 2.1% |
| Q4 25 | -46.8% | 7.8% | ||
| Q3 25 | 80.8% | 20.7% | ||
| Q2 25 | 114.9% | -7.3% | ||
| Q1 25 | 58.4% | 10.0% | ||
| Q4 24 | 69.2% | 23.9% | ||
| Q3 24 | -23.9% | -11.2% | ||
| Q2 24 | 28.1% | -0.5% | ||
| Q1 24 | 116.3% | -0.5% |
| Q4 25 | $-0.38 | $2.34 | ||
| Q3 25 | $0.61 | $7.76 | ||
| Q2 25 | $0.74 | $-2.95 | ||
| Q1 25 | $0.44 | $3.33 | ||
| Q4 24 | $0.58 | $11.56 | ||
| Q3 24 | $-0.17 | $-1.72 | ||
| Q2 24 | $0.23 | $-0.07 | ||
| Q1 24 | $0.98 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $110.2M | $185.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.7B | $329.4M |
| Total Assets | $8.2B | $918.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $110.2M | $185.6M | ||
| Q3 25 | $301.8M | $166.0M | ||
| Q2 25 | $86.5M | $96.7M | ||
| Q1 25 | $67.4M | $84.7M | ||
| Q4 24 | $129.8M | $40.6M | ||
| Q3 24 | $44.1M | $46.9M | ||
| Q2 24 | $145.7M | $40.8M | ||
| Q1 24 | $61.4M | $30.0M |
| Q4 25 | $2.7B | $329.4M | ||
| Q3 25 | $2.7B | $317.2M | ||
| Q2 25 | $2.6B | $235.3M | ||
| Q1 25 | $2.5B | $176.9M | ||
| Q4 24 | $2.4B | $132.4M | ||
| Q3 24 | $2.3B | $60.4M | ||
| Q2 24 | $2.3B | $62.7M | ||
| Q1 24 | $2.3B | $63.0M |
| Q4 25 | $8.2B | $918.5M | ||
| Q3 25 | $8.2B | $964.5M | ||
| Q2 25 | $7.6B | $841.0M | ||
| Q1 25 | $7.5B | $761.9M | ||
| Q4 24 | $7.1B | $655.3M | ||
| Q3 24 | $6.7B | $438.5M | ||
| Q2 24 | $6.7B | $422.4M | ||
| Q1 24 | $6.7B | $404.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $167.3M | $70.4M |
| Free Cash FlowOCF − Capex | — | $69.0M |
| FCF MarginFCF / Revenue | — | 45.5% |
| Capex IntensityCapex / Revenue | — | 0.9% |
| Cash ConversionOCF / Net Profit | — | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | — | $245.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.3M | $70.4M | ||
| Q3 25 | $-121.8M | $99.5M | ||
| Q2 25 | $79.6M | $27.3M | ||
| Q1 25 | $-37.1M | $51.0M | ||
| Q4 24 | $5.9M | $54.0K | ||
| Q3 24 | $21.9M | $6.8M | ||
| Q2 24 | $-24.8M | $13.3M | ||
| Q1 24 | $20.9M | $3.1M |
| Q4 25 | — | $69.0M | ||
| Q3 25 | — | $99.2M | ||
| Q2 25 | — | $26.5M | ||
| Q1 25 | — | $50.9M | ||
| Q4 24 | — | $-341.0K | ||
| Q3 24 | — | $6.2M | ||
| Q2 24 | — | $12.7M | ||
| Q1 24 | — | $2.3M |
| Q4 25 | — | 45.5% | ||
| Q3 25 | — | 37.0% | ||
| Q2 25 | — | 10.9% | ||
| Q1 25 | — | 24.0% | ||
| Q4 24 | — | -0.1% | ||
| Q3 24 | — | 7.8% | ||
| Q2 24 | — | 16.7% | ||
| Q1 24 | — | 3.4% |
| Q4 25 | — | 0.9% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 0.7% | ||
| Q1 24 | — | 1.1% |
| Q4 25 | — | 5.95× | ||
| Q3 25 | -1.46× | 1.80× | ||
| Q2 25 | 0.81× | — | ||
| Q1 25 | -0.66× | 2.40× | ||
| Q4 24 | 0.08× | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | -0.94× | — | ||
| Q1 24 | 0.17× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HASI
Segment breakdown not available.
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
